Patients with glaucoma are not at an increased risk of developing systemic vascular disease, according to a study published in the August 2008 issue of the Acta Ophthalmologica.
Patients with glaucoma are not at an increased risk of developing systemic vascular disease, according to a study published in the August 2008 issue of the Acta Ophthalmologica.
Ahti Tarkkanen, MD of the Department of Ophthalmology, Helsinki University Central Hospital, Finland and colleagues conducted a medical record review of glaucomatous patients (n=499) admitted to Finnish hospitals to assess any possible link between primary open-angle glaucoma (POAG; n=344) or exfoliation glaucoma (EG; n=155) and arterial hypertension (HT), ischaemic heart disease (IHD), cerebrovascular incidents or abdominal aorta aneurysm. Patients in the POAG group were younger and more likely to have diabetes mellitus (DM), a known cardiovascular disease risk factor, than patients in the EG group.
After adjusting for traditional risk factors, the team found no difference in the level of HT, IHD or cardiovascular incidents between the study subjects and the general population.
Therefore, the team concluded that neither POAG nor EG is a risk factor for the development of systemic vascular disease.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.